✦ LIBER ✦

Gene aberrations ofRRM1andRRM2Band outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine

✍ Scribed by Jørgensen, Charlotte LT; Ejlertsen, Bent; Bjerre, Karsten D; Balslev, Eva; Nielsen, Dorte L; Nielsen, Kirsten V

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Neoadjuvant Gemcitab

✍ Denise A. Yardley; Nancy W. Peacock; Natalie R. Dickson; Melissa B. White; Eliza 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 609 KB

Recurrence Rates after Treatment of Brea

✍ Bartelink, Harry; Horiot, Jean-Claude; Poortmans, Philip; Struikmans, Henk; Van 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 138 KB

The outcome of patients with breast canc

✍ Masakuni Noguchi; Koichiro Tsugawa; Takao Taniya; Koichi Miwa 📂 Article 📅 1999 🏛 Springer Japan 🌐 English ⚖ 818 KB

Phase II study of neoadjuvant treatment

✍ Gumersindo Pérez Manga; Parham Khosravi Shahi; Miguel Méndez Ureña; Rosa Quiben 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 214 KB

A Phase II Trial of Gemcitabine/Carbopla

✍ Denise A. Yardley; Howard A. Burris III; Lisa Simons; David R. Spigel; F. Anthon 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB

Phase II Multicenter Study of Docetaxel

✍ Schwartzberg, Lee S.; Badarinath, Suprith; Keaton, Mark R.; Childs, Barrett H. 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 451 KB